Neurotensin Branched Peptide as a Tumor-Targeting Agent for Human Bladder Cancer

<div>Binding and internalization (0 h, 1 h, 2 h, and 4 h) of NT4 (red) on HT-1376 human bladder cell carcinoma (a) and T24 urinary bladder transitional cell carcinoma (b). Nuclei are stained with DAPI (blue) and plasma membrane is stained with Lectin-FITC (green).</div>

BioMed Research International

fig1

Figure 1

Figure 1: Neurotensin Branched Peptide as a Tumor-Targeting Agent for Human Bladder Cancer 